REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
13/10/2025
Voltar para busca
Dado oficial do USPTO
FORESENTIA SOMATIC CANCER NIPD GENETICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
45
Atualização mais recente
14/10/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 42, 44
Data de depósito
18/12/2019
Data de registro
13/10/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
13/10/2020
Última transação
14/10/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
99
Localização do titular
CY
Examinador
NEVILLE, BRIAN
Unidade examinadora
M50
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of three lines of stylized wording. The first line is "NIPD GENETICS" in gray in stylized form. The second line is "FORESENTIA" in stylized form, where "FORE" is in orange and "SENTIA" is in gray. The third line is "SOMATIC CANCER" in orange.
Titulares e representantes
Titulares
MEDICOVER PUBLIC CO LTD
NIPD Genetics Public Company Limited
Representantes
Paulo A. de Almeida Patel & Almeida PC
Classificação técnica
Classes Nice
Classe 1Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical analysis kits composed of reagents for genetic testing for medical and scientific research purposes in the field of cancer detection; chemical analysis kits composed of reagents for cancer testing for medical and scientific research purposes; nucleic acid based kits composed of reagents for testing cancer diseases for medical and scientific research purposes
Classe 42
Medical laboratory services for testing of cancer and cancer prevention; design and development of medical diagnostic tests and products; medical and scientific research in the field of genetic testing; providing medical and scientific research information in the field of genetic testing; genetic testing for scientific research and analysis purposes in the field of cancer detection; genetic engineering services; scientificlaboratoryclinicalmedicaltechnological research and analysis services in the fields of nucleic acid analysiscancer testinggenetics; scientific research for medical purposes in the area of cancerous diseases
Classe 44
Medical analysis services for the diagnosis and prognosis of cancer; medical genetic testing services for diagnosisprevention and treatment of cancer; medical testing of blood for diagnosis of cancer; genetic testing and genetic counseling in the field of cancer detection; medical and health services relating to DNA and genetics testing; RNA or DNA analysis for cancer diagnosis and prognosis
Publicações
Histórico de despachos e eventos da marca no USPTO.
45 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
16/01/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
14/06/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
14/06/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
14/06/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
02/12/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
29/10/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
23/09/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
23/09/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
23/09/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
23/09/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
21/02/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/02/2021
FIMP
FINAL DISPOSITION PROCESSED
01/02/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
13/01/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
13/10/2020
GPNX
NOTIFICATION PROCESSED BY IB
31/07/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/07/2020
PUBO
PUBLISHED FOR OPPOSITION
28/07/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
15/07/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
15/07/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/07/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
18/06/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
15/06/2020
ALIE
ASSIGNED TO LIE
15/06/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/06/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
12/06/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/06/2020
RFNT
REFUSAL PROCESSED BY IB
05/06/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/05/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/05/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/05/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
26/05/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
26/05/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
26/05/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
26/05/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
26/05/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
18/05/2020
RFRR
REFUSAL PROCESSED BY MPU
18/05/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/05/2020
CNRT
NON-FINAL ACTION WRITTEN
01/05/2020
MAFR
APPLICATION FILING RECEIPT MAILED
28/04/2020
DOCK
ASSIGNED TO EXAMINER
24/04/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
24/04/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
23/04/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace FORESENTIA SOMATIC CANCER NIPD GENETICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.